A Phase Ib Study Evaluating the Safety and Tolerability of Vitamin C in Patients With Intermediate or High Risk Myelodysplastic Syndrome With TET2 Mutations
PHASE1
This is an open label, Phase Ib study designed to evaluate the safety, toxi...
Status
Completed
Location
University of Miami Miller School of Medicine -Sylvester Cancer Center
Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer
PHASE2
This is a phase II, single arm, Simon two-stage design, trial, enrolling pa...
Status
Recruiting
Location
Holden Comprehensive Cancer Center - The University of Iowa